ABT vs OFG · P/E 25, rev $44.33B vs P/E 9.6, rev $391.3M
Abbott Laboratories (ABT) versus OFG Bancorp (OFG) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
OFG Bancorp (OFG) is a banks - regional company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported OFG revenue for 2026-06-30 was $391.3M. Net income was $112.7M. OFG currently screens at market cap $1.97B and trailing P/E 9.6.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. OFG currently screens at market cap $1.97B and trailing P/E 9.6.
Not investment advice. Open the ABT and OFG stock pages for the full models.
Not investment advice.